VERSES AI Secures $5.2 Million in Recent Funding Rounds for AI Development

VERSES AI Completes Multi-Tranche Funding Rounds

VERSES AI Inc. (CBOE: VERS) (OTC: VRSSF), a cognitive computing company, has successfully closed multiple private placement offerings, raising a total of $5.2 million to fuel its AI development initiatives 1

1

2

2

3

3

. The company, known for its nature-inspired intelligent software systems, completed these funding rounds in November 2024.

Breakdown of the Funding Rounds

The funding was secured through various offerings:

1. LIFE Offering:

   • First tranche: $2,903,850 raised on November 8, 2024 2

     2

   • Second tranche: $512,800 raised on November 15, 2024 1

     1

   • Total LIFE Offering: $3,416,650

2. Special Warrant Offering:

   • Closed on November 8, 2024
   • Raised $1,800,000 3

     3

Structure of the Offerings

The LIFE Offering consisted of LIFE Units priced at $0.50 each, comprising:

• One Class A Subordinate Voting share
• One-half of a Share purchase warrant

The Special Warrant Offering involved:

• 3,600,000 special warrants at $0.50 each
• Each special warrant convertible into one Equity Unit

Both offerings included warrants exercisable at $0.75 per Share for 36 months 1

1

2

2

3

3

.

Utilization of Funds

VERSES plans to allocate the net proceeds for:

1. General working capital
2. Funding ongoing operations
3. Research and development, with a focus on Genius™, their flagship product 1

   1

   2

   2

Genius™: VERSES' AI Innovation

Genius™ is described as a toolkit for developers to create intelligent software agents capable of reasoning, planning, and learning. This product aligns with VERSES' mission to build next-generation intelligent software systems inspired by nature's principles 1

1

2

2

3

3

.

Market Impact and Investor Interest

The successful completion of these offerings, including an upsizing of the Special Warrant Offering from $1.5 million to $1.8 million, indicates strong investor interest in VERSES' AI technology 3

3

. The company's ability to secure funding in multiple tranches suggests confidence in its business model and growth potential.

Regulatory Considerations

The offerings were conducted under various exemptions from prospectus requirements, including the listed issuer financing exemption for the LIFE Offering, allowing for freely tradeable securities in Canada. However, U.S. investors face restrictions under the 1933 Securities Act 1

1

2

2

3

3

.

Future Outlook

While VERSES expresses optimism about its funding success and development plans, it cautions investors about forward-looking statements. The company acknowledges that actual results may differ from expectations due to various risk factors and uncertainties in the AI and technology sectors 1

1

2

2

3

3

4

4

.